View Studies by Location
View Virtual Studies
View Compensated Studies
View Studies by Health Condition
Our Method
Our Process
Virtual & Survey Research
Recruit With Us
Time-Saving Technology
Positive Participant Experience
Enrollment Best Practices
Performance Metrics
Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Woolcock Institute of Medical Research
Location: Glebe Point Rd, Glebe, Sydney, NSW (click for map)
Lead Doctor:Professor Peter Gibson
Ethics Committee: Approved by the Hunter New England Health Research Ethics Committee
The AMAZES Study research team is aiming to determine whether taking an antibiotic (Azithromycin) alongside normal asthma medications helps to reduce the number of asthma ‘attacks’ and general daily symptoms experienced by adults with asthma. Those patients for whom this study is suitable will be randomly allocated to take either Azithromycin or placebo tablets over a 48-week period (neither participants nor investigators will know which medication is being taken until the end of the study). Participants will have their asthma closely monitored over the 48-week period and monitoring will continue for an additional 48 weeks after the treatment has ended. Participants will not need to stop taking their regular asthma medication.
- Adults with asthma (aged 18 and over)
- who are non-smokers (or ex smokers) and
- who experience symptoms despite taking regular preventer medication